AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration

Sweden

1 December 2019 - 30 November 2020

Research collaboration: AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration is a research collaboration whose article contributions are accrued to its participating partner institutions.

Partner Institutions

AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs